Focused update of ESC Heart Failure Guidelines integrates latest evidence-based treatments

A focused update of the European Society of Cardiology (ESC) Heart Failure Guidelines is published online today in European Heart Journal following the results of major new trials that should change the management of patients with heart failure.

Novartis shares updated data for BTK inhibitor; Astellas resubmits BLA for cancer drug after CRL

Plus, news about Valar Labs, Pharming Group and Day One Pharmaceuticals: Novartis outlines one-year data for BTK inhibitor: The drug, called remibrutinib, Sign up to

June 1, 2024

Pediatric-Onset Multiple Sclerosis

Recent research has shed new light on multiple sclerosis (MS) in children, who make up about 3% to 5% of the MS population. At one

June 13, 2024

New biomarker could predict response to IBD treatment

Not everyone responds equally well to treatments for inflammatory bowel disease (IBD). What will work for individual patients involves trial and error during the treatment

November 8, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.